Ira Duarte

Insider Reports History

Location
Cary, NC
Signature
/s/Kathryn Lester Attorney-in-fact for Ira Duarte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ira Duarte:

Company Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Restricted Stock Units 140,332 $493,970 $2.64 31 Jan 2026 Direct
TerrAscend Corp. Director Common Shares 657,930 $256,592 $0.3900 24 Jun 2025 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Common Stock 195,356 $253,962 $1.30 31 Jan 2026 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Employee Stock Option (Right to Buy) 374,220 31 Jan 2025 Direct
HERON THERAPEUTICS, INC. /DE/ EVP, Chief Financial Officer Performance Stock Units 216,561 30 Jan 2026 Direct

Insider Reports Filed by Ira Duarte

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2026 2 $0 4 EVP, Chief Financial Officer 03 Feb 2026, 08:30
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Jan 2026 2 $0 4 EVP, Chief Financial Officer 03 Feb 2026, 10:00
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2026 2 $0 4 EVP, Chief Financial Officer 20 Jan 2026, 14:49
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Oct 2025 2 $0 4 EVP, Chief Financial Officer 04 Nov 2025, 12:33
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2025 2 $0 4 EVP, Chief Financial Officer 21 Oct 2025, 11:42
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2025 2 $0 4 EVP, Chief Financial Officer 04 Aug 2025, 17:27
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2025 2 $0 4 EVP, Chief Financial Officer 22 Jul 2025, 12:23
TSNDF TerrAscend Corp. 24 Jun 2025 1 $0 4 Director 25 Jun 2025, 16:55
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Jun 2025 2 $0 4 EVP, Chief Financial Officer 17 Jun 2025, 17:53
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Apr 2025 2 $0 4 EVP, Chief Financial Officer 02 May 2025, 20:32
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2025 2 $0 4 EVP, Chief Financial Officer 22 Apr 2025, 09:57
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2025 2 $0 4 EVP, Chief Financial Officer 04 Feb 2025, 12:44
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2025 2 $0 4 EVP, Chief Financial Officer 22 Jan 2025, 09:32
TSNDF TerrAscend Corp. 31 Dec 2024 1 -$46,608 4 Director 03 Jan 2025, 16:04
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2024 2 $0 4 EVP, Chief Financial Officer 21 Oct 2024, 15:55
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2024 2 $0 4 EVP, Chief Financial Officer 22 Jul 2024, 09:32
TSNDF TerrAscend Corp. 17 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:30
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Jun 2024 2 $0 4 EVP, Chief Financial Officer 17 Jun 2024, 14:21
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2024 3 -$2,962 4 EVP, Chief Financial Officer 19 Apr 2024, 17:48
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2024 2 $0 4 EVP, Chief Financial Officer 19 Jan 2024, 21:00
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Nov 2023 1 +$75,599 4 EVP, Chief Financial Officer 17 Nov 2023, 12:36
TSNDF TerrAscend Corp. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 14:44
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Jun 2023 0 $0 3 EVP, Chief Financial Officer 23 Jun 2023, 16:28
TSNDF TerrAscend Corp. 01 Dec 2022 0 $0 3 Director 09 Dec 2022, 16:07